ERCC2 and non-Hodgkin lymphoma: The data presented by Chen et al. following the case–control study in Connecticut revealed that the women with a BMI (body mass index) > 25 who carried the AA genotype of XPD 2251A>C had a significantly lower risk of developing NHL (OR = 2; 95% CI = 1.4–3) [61].